IFG Advisory’s Pliant Therapeutics PLRX Stock Holding History

IFG Advisory’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5	Buy	+4	New	+$5	﹤0.01%	2356

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

IFG Advisory's PLRX Position: Q2 2026 in Review

IFG Advisory opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 4 shares worth $5. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings.

86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

IFG Advisory held 4 shares of Pliant Therapeutics worth $5 as of Q2 2026.
Pliant Therapeutics was a new IFG Advisory position in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of IFG Advisory's portfolio in Q2 2026, its #2356 holding.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.